Related references
Note: Only part of the references are listed.Features of polymyalgia rheumatica-like syndrome after immune checkpoint inhibitor therapy
Gregoire Martin de Fremont et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging
Ting Martin Ma et al.
EUROPEAN UROLOGY ONCOLOGY (2022)
Kinetic modeling and parametric imaging with dynamic PET for oncological applications: general considerations, current clinical applications, and future perspectives
Antonia Dimitrakopoulou-Strauss et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings
Haojun Chen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
A decade of radiomics research: are images really data or just patterns in the noise?
Daniel Pinto dos Santos et al.
EUROPEAN RADIOLOGY (2021)
Quantitative PET in the 2020s: a roadmap
Steven R. Meikle et al.
PHYSICS IN MEDICINE AND BIOLOGY (2021)
Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study
Daniela A. Ferraro et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
Francesco Ceci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
Michael S. Hofman et al.
LANCET (2021)
Medical imaging and nuclear medicine: a Lancet Oncology Commission
Hedvig Hricak et al.
LANCET ONCOLOGY (2021)
Response Rates to Anti-PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase
Cristina Valero et al.
JAMA ONCOLOGY (2021)
Artificial intelligence for reduced dose 18F-FDG PET examinations: a real-world deployment through a standardized framework and business case assessment
Katia Katsari et al.
EJNMMI PHYSICS (2021)
Evaluation of an Automatic Classification Algorithm Using Convolutional Neural Networks in Oncological Positron Emission Tomography
Pierre Pinochet et al.
FRONTIERS IN MEDICINE (2021)
68Ga-fibroblast activation protein inhibitor PET/CT on gross tumour volume delineation for radiotherapy planning of oesophageal cancer
Liang Zhao et al.
RADIOTHERAPY AND ONCOLOGY (2021)
PET imaging of immune checkpoint proteins in oncology
Alizee Bouleau et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Total-Body Dynamic Reconstruction and Parametric Imaging on the uEXPLORER
Xuezhu Zhang et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
PennPET Explorer: Design and Preliminary Performance of a Whole-Body Imager
Joel S. Karp et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Ga-68-PSMA I&T PET/CT for primary staging of prostate cancer
Wojciech Cytawa et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models
Tadashi Watabe et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Radiomics of 18F-FDG PET/CT images predicts clinical benefit of advanced NSCLC patients to checkpoint blockade immunotherapy
Wei Mu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Radiation Dosimetry and Biodistribution of 68Ga-FAPI-46 PET Imaging in Cancer Patients
Catherine Meyer et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Immunoactivating the tumor microenvironment enhances immunotherapy as predicted by integrative computational model
Aleksander S. Popel
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
18F-FDG PET/CT Uptake Classification in Lymphoma and Lung Cancer by Using Deep Convolutional Neural Networks
Ludovic Sibille et al.
RADIOLOGY (2020)
Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial
Heiko Schoder et al.
BLOOD (2020)
A convolutional neural network-based system to classify patients using FDG PET/CT examinations
Keisuke Kawauchi et al.
BMC CANCER (2020)
PSMA-targeted Radiotracers versus 18F Fluciclovine for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis
Nelly Tan et al.
RADIOLOGY (2020)
The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping
Alex Zwanenburg et al.
RADIOLOGY (2020)
Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial
Wolfgang P. Fendler et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
Michael S. Hofman et al.
LANCET (2020)
PSMA Theranostics: Review of the Current Status of PSMA-Targeted Imaging and Radioligand Therapy
Wallace Jones et al.
CANCERS (2020)
18F-FDG PET and DCE kinetic modeling and their correlations in primary NSCLC: first voxel-wise correlative analysis of human simultaneous [18F]FDG PET-MRI data
Florent L. Besson et al.
EJNMMI RESEARCH (2020)
Harmonization strategies for multicenter radiomics investigations
R. Da-Ano et al.
PHYSICS IN MEDICINE AND BIOLOGY (2020)
Cancer-associated fibroblasts an their influence on tumor immunity and immunotherapy
Richard Lee Barrett et al.
ELIFE (2020)
68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers
Frederik L. Giesel et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Neuroendocrine differentiation of prostate cancer leads to PSMA suppression
Martin K. Bakht et al.
ENDOCRINE-RELATED CANCER (2019)
First Human Imaging Studies with the EXPLORER Total-Body PET Scanner
Ramsey D. Badawi et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Imaging of Prostate Specific Membrane Antigen Targeted Radiotracers for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis
Nelly Tan et al.
JOURNAL OF UROLOGY (2019)
Monitoring anti-PD-1-based immunotherapy in non-small cell lung cancer with FDG PET: introduction of iPERCIST
Lucas Goldfarb et al.
EJNMMI RESEARCH (2019)
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial
Wolfgang P. Fendler et al.
JAMA ONCOLOGY (2019)
68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
Clemens Kratochwil et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics
Romain-David Seban et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Novel patterns of response under immunotherapy
E. Borcoman et al.
ANNALS OF ONCOLOGY (2019)
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0
Ian Law et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
FDG PET/CT for assessing tumour response to immunotherapy: Report on the EANM symposium on immune modulation and recent review of the literature
Nicolas Aide et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Prognostic analysis of interim 18F-FDG PET/CT in patients with diffuse large B cell lymphoma after one cycle versus two cycles of chemotherapy
Ling Yuan et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Metaanalysis of 68Ga-PSMA-11 PET Accuracy for the Detection of Prostate Cancer Validated by Histopathology
Thomas A. Hope et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Turning foes to friends: targeting cancer-associated fibroblasts
Xueman Chen et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Deep Learning-Based Image Segmentation on Multimodal Medical Imaging
Zhe Guo et al.
IEEE TRANSACTIONS ON RADIATION AND PLASMA MEDICAL SCIENCES (2019)
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
Alyson Haslam et al.
JAMA NETWORK OPEN (2019)
Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab
Hoda Anwar et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Guidelines on nuclear medicine imaging in neuroblastoma
Zvi Bar-Sever et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
The role of interim 18F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma
Christos Sachpekidis et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Repeatability and Reproducibility of Radiomic Features: A Systematic Review
Alberto Traverso et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial
Ulrich Duehrsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts
Anastasia Loktev et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
A Postreconstruction Harmonization Method for Multicenter Radiomic Studies in PET
Fanny Orlhac et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
NCCN Guidelines® Insights Neuroendocrine and Adrenal Tumors, Version 2.2018 Featured Updates to the NCCN Guidelines
Manisha H. Shah et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
Michael S. Hofman et al.
LANCET ONCOLOGY (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non-Small Cell Lung Cancer
Koji Haratani et al.
JAMA ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Lu-177-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours: response to treatment and long-term survival update
Emre Demirci et al.
NUCLEAR MEDICINE COMMUNICATIONS (2018)
Zr-89-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
Frederike Bensch et al.
NATURE MEDICINE (2018)
Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer
A. N. Niemeijer et al.
NATURE COMMUNICATIONS (2018)
Standardization of 18F-FDG PET/CT According to Deauville Criteria for MRD Evaluation in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients: Joined Analysis of Two Prospective Randomized Phase III Trials
Elena Zamagni et al.
BLOOD (2018)
Prostate cancer-specific PET radiotracers: A review on the clinical utility in recurrent disease
Jaden D. Evans et al.
PRACTICAL RADIATION ONCOLOGY (2018)
Assessment of Total Lesion Glycolysis by 18F FDG PET/CT Significantly Improves Prognostic Value of GEP and ISS in Myeloma
James E. McDonald et al.
CLINICAL CANCER RESEARCH (2017)
Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1
Stephane Champiat et al.
CLINICAL CANCER RESEARCH (2017)
Synthesis and pre-clinical evaluation of a new class of high-affinity 18F-labeled PSMA ligands for detection of prostate cancer by PET imaging
James Kelly et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Preclinical Evaluation of 18F-PSMA-1007, a New Prostate-Specific Membrane Antigen Ligand for Prostate Cancer Imaging
Jens Cardinale et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer
Christopher C. Riedl et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies
Nicolas Aide et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point 18F-FDG PET/CT Imaging in Patients with Advanced Melanoma
Steve Y. Cho et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging
Anders Sundin et al.
NEUROENDOCRINOLOGY (2017)
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J. Strosberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Ten quick tips for machine learning in computational biology
Davide Chicco
BIODATA MINING (2017)
Comparison of machine learning methods for classifying mediastinal lymph node metastasis of non-small cell lung cancer from 18F-FDG PET/CT images
Hongkai Wang et al.
EJNMMI RESEARCH (2017)
FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study
R. -O. Casasnovas et al.
BLOOD (2017)
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)
A. Younes et al.
ANNALS OF ONCOLOGY (2017)
Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe)
Cristina Nanni et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Comparison of diagnostic accuracy of 111In-pentetreotide SPECT and 68Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours
S. Van Binnebeek et al.
EUROPEAN RADIOLOGY (2016)
Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy
Bruce D. Cheson et al.
BLOOD (2016)
Comparison of RECIST, EORTC criteria and PERCIST for evaluation of early response to chemotherapy in patients with non-small-cell lung cancer
Jingjie Shang et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
PET/CT with 18F-choline after radical prostatectomy in patients with PSA ≤2 ng/ml. Can PSA velocity and PSA doubling time help in patient selection?
Agostino Chiaravalloti et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
11C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series
Tiziano Graziani et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Assessment of Imaging Modalities and Response Metrics in Ewing Sarcoma: Correlation With Survival
Vadim S. Koshkin et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer
Naoya Harada et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
68Ga-PSMA PET/CT Detects the Location and Extent of Primary Prostate Cancer
Wolfgang P. Fendler et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer
Steven P. Rowe et al.
MOLECULAR IMAGING AND BIOLOGY (2016)
ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas
R. Garcia-Carbonero et al.
NEUROENDOCRINOLOGY (2016)
Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors A Review
Claire F. Friedman et al.
JAMA ONCOLOGY (2016)
The High-grade (WHO G3) Pancreatic Neuroendocrine Tumor Category Is Morphologically and Biologically Heterogenous and Includes Both Well Differentiated and Poorly Differentiated Neoplasms
Olca Basturk et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement
Gary S. Collins et al.
BMC MEDICINE (2015)
A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities
M. Vallieres et al.
PHYSICS IN MEDICINE AND BIOLOGY (2015)
Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
James P. B. O'Connor et al.
CLINICAL CANCER RESEARCH (2015)
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
False Discovery Rates in PET and CT Studies with Texture Features: A Systematic Review
Anastasia Chalkidou et al.
PLOS ONE (2015)
Predicting Response to Neoadjuvant Chemotherapy with PET Imaging Using Convolutional Neural Networks
Petros-Pavlos Ypsilantis et al.
PLOS ONE (2015)
PET/CT Imaging in Cancer: Current Applications and Future Directions
Michael D. Farwell et al.
CANCER (2014)
A review on segmentation of positron emission tomography images
Brent Foster et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2014)
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
Sally F. Barrington et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Quantitative and Qualitative Intrapatient Comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: Net Uptake Rate for Accurate Quantification
Irina Velikyan et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
High Prognostic Value of 18F-FDG PET for Metastatic Gastroenteropancreatic Neuro endocrine Tumors: A Long-Term Evaluation
Haifa Bahri et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
Hariharan Easwaran et al.
MOLECULAR CELL (2014)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2014)
Quantitative and qualitative analysis of metabolic response at interim positron emission tomography scan combined with International Prognostic Index is highly predictive of outcome in diffuse large B-cell lymphoma
Nathalie Nols et al.
LEUKEMIA & LYMPHOMA (2014)
Impact of PET-CT Response on Survival Parameters Following Autologous Stem Cell Transplantation Among Patients with Multiple Myeloma: Comparison of Two Cut-Off Values
Meral Beksac et al.
BLOOD (2014)
Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3
Saad Z. Usmani et al.
BLOOD (2013)
Choline PET or PET/CT and Biochemical Relapse of Prostate Cancer A Systematic Review and Meta-Analysis
Laura Evangelista et al.
CLINICAL NUCLEAR MEDICINE (2013)
Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma
Silvia Fuertes et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumours
Stefano Severi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis
Hakan Geijer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax
Emmanuel Itti et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Response Criteria in Oncologic Imaging: Review of Traditional and New Criteria
Temel Tirkes et al.
RADIOGRAPHICS (2013)
Radiomics: Extracting more information from medical images using advanced feature analysis
Philippe Lambin et al.
EUROPEAN JOURNAL OF CANCER (2012)
Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis
Giorgio Treglia et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Modern Nuclear Imaging for Paragangliomas: Beyond SPECT
David Taieb et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Evaluation of Response to Neoadjuvant Chemotherapy for Esophageal Cancer: PET Response Criteria in Solid Tumors Versus Response Evaluation Criteria in Solid Tumors
Masahiro Yanagawa et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Metabolic Tumor Volume Assessed by 18F-FDG PET/CT for the Prediction of Outcome in Patients with Multiple Myeloma
Rosa Fonti et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Evaluation of Breast Tumor Blood Flow with Dynamic First-Pass 18F-FDG PET/CT: Comparison with Angiogenesis Markers and Prognostic Factors
Alexandre Cochet et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma
Rene -Olivier Casasnovas et al.
BLOOD (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
IMPACT OF [18F]FLUORODEOXYGLUCOSE PET-CT STAGING ON TREATMENT PLANNING IN RADIOTHERAPY INCORPORATING ELECTIVE NODAL IRRADIATION FOR NON-SMALL-CELL LUNG CANCER: A PROSPECTIVE STUDY
Milena Kolodziejczyk et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Functional Imaging of SDHx-Related Head and Neck Paragangliomas: Comparison of 18F-Fluorodihydroxyphenylalanine, 18F-Fluorodopamine, 18F-Fluoro-2-Deoxy-D-Glucose PET, 123I-Metaiodobenzylguanidine Scintigraphy, and 111In-Pentetreotide Scintigraphy
Kathryn S. King et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
68Ga-DOTATOC Versus 68Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine Tumors
Thorsten D. Poeppel et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner
Gaspar Delso et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Initial performance evaluation of the Biograph mMR
Sebastian Furst et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Comparative Assessment of Methods for Estimating Tumor Volume and Standardized Uptake Value in 18F-FDG PET
Perrine Tylski et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Multiparametric Imaging of Tumor Response to Therapy
Anwar R. Padhani et al.
RADIOLOGY (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Early Prediction of Response to Sunitinib After Imatinib Failure by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients With Gastrointestinal Stromal Tumor
John O. Prior et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Standards for PET Image Acquisition and Quantitative Data Analysis
Ronald Boellaard
JOURNAL OF NUCLEAR MEDICINE (2009)
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Richard L. Wahl et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Heterogeneity of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Carcinoma with Distant Metastasis
Sebastian Mannweiler et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
Exploring feature-based approaches in PET images for predicting cancer treatment outcomes
I. El Naqa et al.
PATTERN RECOGNITION (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer:: a meta-analysis
A. M. Hovels et al.
CLINICAL RADIOLOGY (2008)
Impact of [18F] fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-hodgkin lymphoma
Andrew Wirth et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: Initial results from the national oncologic PET registry
Bruce E. Hillner et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake:: A comparison with 15O-Labeled water-measured blood flow
Nizar A. Mullani et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma:: SUV-based assessment versus visual analysis
Chieh Lin et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
The National Oncologic PET Registry: Expanded medicare coverage for PET under coverage with evidence development
Matthew J. Lindsay et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2007)
Revised response criteria for malignant lymphoma
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction
Katja Ott et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Consecutive patients diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N-and M-staging of malignant melanoma:: Experience with 250 consecutive patients
MJ Reinhardt et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec®)
S Stroobants et al.
EUROPEAN JOURNAL OF CANCER (2003)
A statistical measure of tissue heterogeneity with application to 3D PET sarcoma data
F O'Sullivan et al.
BIOSTATISTICS (2003)
Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial
H van Tinteren et al.
LANCET (2002)
Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC:: preliminary data
M Hofmann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2001)
Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions - A meta-analysis
MK Gould et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
